澳门威士尼斯人(SViP认证)网站-Win win Platform
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
旧版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Proposed Amendments to the Articles of Association
2024-04-25
Announcement Notice of Board Meeting
2024-04-11
Overseas Regulatory Announcement-Announcement on Cefaclor Capsules of Wholly-own
2024-04-10
Overseas Regulatory Announcement-Announcement on Peramivir Injection Having Obtained the Notification of Approval of Supplementary Drug Application
2024-04-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
2024-04-02
Final Dividend for the Year Ended 31 December 2023
2024-03-28
Proposed Amendments to the Articles of Association
2024-03-28
Proposed Change of Auditors
2024-03-28
Announcement Notice of Board Meeting
2024-03-14
Overseas Regulatory Announcement-Announcement on Ibuprofen Sustained Release Capsules Obtaining the Drug Registration Certificate
2024-03-12
<
...
2
3
4
5
6
7
8
...
>